These include your current body mass index (BMI), blood glucose levels, blood pressure, and presence of weight-related conditions such as type 2 diabetes or heart disease risk factors
Plateau Problems: Restarting Weight Loss If your weight loss has stalled while using GLP-1 medications like Semaglutide or Tirzepatide, its normal and fixable
Risk factors, such as obesity, hypertension, dyslipidemia, smoking, and physical inactivity, are associated with an increased incidence and severity of neuropathy
Common signs include: Fatigue and weakness Numbness or tingling in the hands and feet Difficulty walking or balance problems Mood changes, such as depression or anxiety Cognitive difficulties, including memory loss or confusion If not treated, a B12 deficiency can cause serious problems
- Sunscreen prevents new pigmentation
LY3298176 is the development code assigned to tirzepatide during its clinical program